- Article metrics
- Last updated: Tue, 14 May 2024 15:13:26 Z
Immune checkpoint inhibitors enhanced the antitumor efficacy of disitamab vedotin for patients with HER2-positive or HER2-low advanced or metastatic gastric cancer: a multicenter real-world study
Access & Citations
-
- 1130
- Article Accesses
-
- 0
- Web of Science
-
- 1
- CrossRef
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.